A nurse-led personalized care program conducted through a specialty pharmacy prolonged medication persistence among patients with cancer receiving olaparib. Objective: To assess the effects of a nurse ...
Predictors of disseminated intravascular coagulation in patients with acute myeloid leukemia with severe sepsis and septic shock. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I.
Olaparib is the only PARP inhibitor that significantly improves overall survival in PSROC, distinguishing it from other PARP inhibitors. All four PARP inhibitors enhance progression-free survival, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results